MedKoo Cat#: 575705 | Name: FTCTP

Description:

WARNING: This product is for research use only, not for human or veterinary use.

FTCTP is a biochemical that inhibits the production of full-length minus strand DNA in an endogenous reverse transcriptase reaction. It is also used as a chain terminator substrate.

Chemical Structure

FTCTP
FTCTP
CAS#145819-92-7

Theoretical Analysis

MedKoo Cat#: 575705

Name: FTCTP

CAS#: 145819-92-7

Chemical Formula: C8H13FN3O12P3S

Exact Mass: 486.9417

Molecular Weight: 487.18

Elemental Analysis: C, 19.72; H, 2.69; F, 3.90; N, 8.63; O, 39.41; P, 19.07; S, 6.58

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
FTCTP
IUPAC/Chemical Name
Triphosphoric acid, P-((5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolan-2-yl)methyl) ester, (2R-cis)-
InChi Key
OWNUNIUXQSCPFM-IUYQGCFVSA-N
InChi Code
InChI=1S/C8H13FN3O12P3S/c9-5-6(10)11-8(14)12(7(5)13)3-2-28-4(22-3)1-25(15,16)23-27(20,21)24-26(17,18)19/h3-4,13H,1-2H2,(H,15,16)(H,20,21)(H2,10,11,14)(H2,17,18,19)/t3-,4+/m0/s1
SMILES Code
NC1=NC(=O)N([C@@H]2CS[C@H](CP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)C(=C1F)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 487.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, Vance DE, Adimora AA. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00177-20. doi: 10.1128/AAC.00177-20. PMID: 32631821; PMCID: PMC7449168. 2. Nicol MR, Brewers LM, Kashuba ADM, Sykes C. The role of menopause in tenofovir diphosphate and emtricitabine triphosphate concentrations in cervical tissue. AIDS. 2018 Jan 2;32(1):11-15. doi: 10.1097/QAD.0000000000001678. PMID: 29112071; PMCID: PMC7719012.